IndiaTickerLatest filing: Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of The Board Meeting.
ObservedCompany dossier
Transgene Biotek
BSE:TRABI · ISIN INE773D01018
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Transgene Biotek
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 23.64% and public 76.36% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of The Board Meeting.
BSE · exchange filing
Observed
Source filing Transgene Biotek Ltd - 526139 - Compliance-57 (4) : Prior intimation to the beginning of the quarter
BSE · exchange filing
Observed
Source filing Transgene Biotek Ltd - 526139 - Statement Of Deviation & Variation
BSE · exchange filing
Observed
Source filing Transgene Biotek Ltd - 526139 - Compliance-57 (5) : intimation after the end of quarter
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 23.64%
- Public
- 76.36%
- Employee trust
- N/A
Observed BSE shareholding XBRL